- Home
- RMBI vs IPSC Comparison
RMBI vs IPSC Comparison
Compare RMBI & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- IPSC
- Stock Information
- Founded
- RMBI 1887
- IPSC 2019
- Country
- RMBI United States
- IPSC United States
- Employees
- RMBI N/A
- IPSC N/A
- Industry
- RMBI Major Banks
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- RMBI Finance
- IPSC Health Care
- Exchange
- RMBI Nasdaq
- IPSC Nasdaq
- Market Cap
- RMBI 127.9M
- IPSC 149.1M
- IPO Year
- RMBI 2019
- IPSC 2021
- Fundamental
- Price
- RMBI $12.79
- IPSC $1.59
- Analyst Decision
- RMBI
- IPSC Strong Buy
- Analyst Count
- RMBI 0
- IPSC 3
- Target Price
- RMBI N/A
- IPSC $15.00
- AVG Volume (30 Days)
- RMBI 7.6K
- IPSC 366.3K
- Earning Date
- RMBI 10-18-2024
- IPSC 11-07-2024
- Dividend Yield
- RMBI 4.40%
- IPSC N/A
- EPS Growth
- RMBI N/A
- IPSC N/A
- EPS
- RMBI 0.81
- IPSC N/A
- Revenue
- RMBI $41,636,699.00
- IPSC $2,041,000.00
- Revenue This Year
- RMBI N/A
- IPSC $233.38
- Revenue Next Year
- RMBI N/A
- IPSC $34.05
- P/E Ratio
- RMBI $15.77
- IPSC N/A
- Revenue Growth
- RMBI N/A
- IPSC N/A
- 52 Week Low
- RMBI $9.44
- IPSC $1.28
- 52 Week High
- RMBI $13.00
- IPSC $5.51
- Technical
- Relative Strength Index (RSI)
- RMBI 61.17
- IPSC 44.33
- Support Level
- RMBI $11.40
- IPSC $1.48
- Resistance Level
- RMBI $12.80
- IPSC $1.63
- Average True Range (ATR)
- RMBI 0.37
- IPSC 0.14
- MACD
- RMBI 0.00
- IPSC 0.02
- Stochastic Oscillator
- RMBI 95.71
- IPSC 34.70
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.